二氢杨梅素药理作用研究进展  

Research progress in pharmacological effects of dihydromyricelin

作　　者：侯小龙[1] 王文清[1] 施春阳[1] 童庆[1] 方建国[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院药学部,湖北武汉430030

出　　处：《中草药》2015年第4期603-609,共7页Chinese Traditional and Herbal Drugs

基　　金：华中科技大学创新研究院技术创新基金(CXY13Q059)

摘　　要：二氢杨梅素为藤茶中主要的黄酮类化合物,近年来其药理作用受到广泛关注。本文就10余年来二氢杨梅素抗肿瘤、抗炎、抗氧化、解酒护肝、抗病原微生物、降血糖、抗疲劳和调血脂等方面的研究进展进行综述,为二氢杨梅素的深入研究及其植物资源的进一步综合开发利用提供科学依据。As a major flavonoid in the leaves of Ampelopsis grossedentata, dihydromyricelin has attracted the wide attention in recent years. Studies showed that dihydromyricelin has multiple pharmacological effects, such as antitumor, anti-inflammation, anti-oxidation, blood lipid regulation, anti-temulence and liver protection, antidiabetics, and anti-pathogeny microorganism. We made a summary for domestic and foreign study literatures for various pharmacological effects of dihydromyricelin in the recent decade, in the expectation of providing the scientific basis for the in-depth studies, as well as the utilization of dihydromyricelin and its medicinal resource.

关 键 词：二氢杨梅素 黄酮类 抗肿瘤 抗氧化 抗炎 

分 类 号：R285[医药卫生—中药学]